microRNA information: hsa-miR-493-5p
Section | ID | link |
---|---|---|
Mature name: | hsa-miR-493-5p | miRbase |
Accession: | MIMAT0002813 | miRbase |
Precursor name: | hsa-mir-493 | miRbase |
Precursor accession: | MI0003132 | miRbase |
Symbol: | MIR493 | HGNC |
RefSeq ID: | NR_030172 | GenBank |
Sequence: | UUGUACAUGGUAGGCUUUCAUU |
Reported expression in cancers: hsa-miR-493-5p
miRNA | cancer | regulation | reporting | PUBMED | method |
---|---|---|---|---|---|
hsa-miR-493-5p | breast cancer | deregulation | "For identification of differentially expressed mic ......" | 20331864 | qPCR |
hsa-miR-493-5p | colon cancer | upregulation | "Functional analyses showed that miR-493 and to a l ......" | 22373578 | |
hsa-miR-493-5p | gastric cancer | downregulation | "Tissue samples obtained from 36 gastric cancer pat ......" | 26730339 | qPCR; Microarray; in situ hybridization |
Reported cancer pathway affected by hsa-miR-493-5p
miRNA | cancer | pathway | reporting | PUBMED | functional study |
---|
Reported cancer prognosis affected by hsa-miR-493-5p
miRNA | cancer | prognosis | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-493-5p | bladder cancer | motility | "Tumor suppressor microRNA 493 decreases cell motil ......" | 22057916 | Luciferase |
hsa-miR-493-5p | colon cancer | tumorigenesis; metastasis | "miR 493 induction during carcinogenesis blocks met ......" | 22373578 | |
hsa-miR-493-5p | colon cancer | metastasis | "MKK7 mediates miR 493 dependent suppression of liv ......" | 24533778 | RNAi |
hsa-miR-493-5p | gastric cancer | cell migration; staging; metastasis; progression; poor survival | "MiR 493 suppresses the proliferation and invasion ......" | 26730339 | Wound Healing Assay |
hsa-miR-493-5p | gastric cancer | drug resistance | "miR 493 mediated DKK1 down regulation confers prol ......" | 26799283 | |
hsa-miR-493-5p | lung cancer | metastasis; progression | "MicroRNA 493 suppresses tumor growth invasion and ......" | 25105419 |
Reported gene related to hsa-miR-493-5p
miRNA | cancer | gene | reporting | PUBMED |
---|---|---|---|---|
hsa-miR-493-5p | colon cancer | IGF1R | "We previously showed that IGF1R is a target gene o ......" | 24533778 |
hsa-miR-493-5p | colon cancer | IGF1R | "IGF1R was identified as a direct target of miR-493 ......" | 22373578 |
hsa-miR-493-5p | bladder cancer | RHOC | "Tumor suppressor microRNA 493 decreases cell motil ......" | 22057916 |
hsa-miR-493-5p | gastric cancer | RHOC | "MiR 493 suppresses the proliferation and invasion ......" | 26730339 |
hsa-miR-493-5p | gastric cancer | DKK1 | "miR 493 mediated DKK1 down regulation confers prol ......" | 26799283 |
hsa-miR-493-5p | lung cancer | E2F1 | "MicroRNA 493 suppresses tumor growth invasion and ......" | 25105419 |
hsa-miR-493-5p | gastric cancer | FRTS1 | "Moreover miR-493 might independently predict OS an ......" | 26730339 |
hsa-miR-493-5p | breast cancer | FUT4 | "miR 493 5p attenuates the invasiveness and tumorig ......" | 27375041 |
hsa-miR-493-5p | bladder cancer | FZD4 | "Tumor suppressor microRNA 493 decreases cell motil ......" | 22057916 |
hsa-miR-493-5p | chronic myeloid leukemia | IL8 | "These criteria narrowed our candidate gene-miRNA t ......" | 25506832 |
hsa-miR-493-5p | colon cancer | MAP2K7 | "MKK7 mediates miR 493 dependent suppression of liv ......" | 24533778 |
Expression profile in cancer corhorts:
Putative target regulations
miRNA | Gene | Cancer | Interaction | Correlation beta |
---|---|---|---|---|
hsa-miR-493-5p | STXBP3 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; OV; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.073; TCGA BRCA -0.052; TCGA COAD -0.097; TCGA ESCA -0.07; TCGA HNSC -0.05; TCGA OV -0.053; TCGA SARC -0.067; TCGA STAD -0.086; TCGA UCEC -0.106 |
hsa-miR-493-5p | PDK4 | 9 cancers: BRCA; ESCA; KIRC; LIHC; LUAD; LUSC; PRAD; SARC; STAD | MirTarget | TCGA BRCA -0.213; TCGA ESCA -0.765; TCGA KIRC -0.159; TCGA LIHC -0.155; TCGA LUAD -0.161; TCGA LUSC -0.268; TCGA PRAD -0.221; TCGA SARC -0.164; TCGA STAD -0.753 |
hsa-miR-493-5p | VAMP2 | 9 cancers: BRCA; COAD; ESCA; LUAD; LUSC; OV; PAAD; PRAD; STAD | miRNATAP | TCGA BRCA -0.14; TCGA COAD -0.125; TCGA ESCA -0.097; TCGA LUAD -0.062; TCGA LUSC -0.116; TCGA OV -0.071; TCGA PAAD -0.149; TCGA PRAD -0.094; TCGA STAD -0.202 |
hsa-miR-493-5p | MPP7 | 10 cancers: COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; SARC; STAD; UCEC | MirTarget | TCGA COAD -0.202; TCGA ESCA -0.228; TCGA HNSC -0.124; TCGA LUAD -0.112; TCGA LUSC -0.153; TCGA OV -0.143; TCGA PAAD -0.289; TCGA SARC -0.505; TCGA STAD -0.475; TCGA UCEC -0.131 |
Enriched cancer pathways of putative targets